Abstract:Telomere is a nucleoprotein complex which caps the extreme ends of eukaryotic chromosomes. In human, telomere is composed of a tandem repeat array of TTAGGG hexanucleotide and bound to a set of specific proteins. These proteins function to maintain the integrity of chromosomes and genomic stability. Among these proteins, telomere repeat binding factor 1(TRF1) is the first telomere binding protein which was isolated by DNA affinity chromatography in 1995. TRF1 serves as a negative regulator of telomere length since TRF1 overexpression would elicit the shortening of telomere length in telomerase-positive cells. Meanwhile, overexpression of TRF1 would also induce the entry into mitosis and increase mitotic cells. These observation indicated TRF1 might participate in cell cycle regulation. However, the underlying mechanism in which TRF1 regulates the cell cycle and the endogenous level of TRF1 were not well-documented during cell cycle progression. To address these questions, we arrested HeLa cells at different phases by a combination of thymidine(5mM at final concentration) and nocodazole(20mM at final concentration) and detected the TRF1 levels by semi-quantitive Western Blotting assay. Cell cycle was verified by flow cytometry. Our results showed TRF1 level fluctuated coincided with cell cycle progression which reached the zenith at the M phase and went down to the nadir at G1/S point. Densitometry analysis demonstrated that the level of TRF1 at M phase was 3.9 times more than that at G1/S point(n=3, p<0.01). These results suggested that TRF1 might be essential for proper cell cycle progression and it was likely to take part in regulation of cell cycle chechpoint. TRF1 is also expressed in telomerase-negative cells. To further discriminate the different functions of TRF1 and decipher its protein-protein interaction network in telomerase-positive and negative cells, full-length TRF1 cDNA was amplified by PCR and subsequently subcloned into pEGFP-C2 vector to express TRF1 tagged by enhanced green fluorescent protein. This construct was then transiently transfected into telomerase-negative cells(WI38-2RA) and telomerase-positive cells(HeLa). Immunoflourescent staining was employed to check the localization of TRF1 in these two kinds of cells. Although in both cells, TRF1 was distributed in a speckled pattern in the nuclei, TRF1 did exclusively colocalize with promyelocytic leukemia(PML) nuclear body in WI38-2RA cells but not in HeLa cells. PML fused with RARα due to chromosome15,17 translocation which led to disassembly of PML nucleur body in acute promyelocytic leukemia. These preliminary results suggested that TRF1 might have the different regulating mechanism and interacting network.

[Expression of Human Telomere Repeat Binding Factor 1 (TRF1) in Acute Leukemia Cells and Its Correlation with Telomerase Activities].

[Expression of telomere binding factor 2 (TRF2) on leukemia cell lines and primary leukemia cells].

[Expression of Telomere Repeat Binding Factor 1 (TRF1) Protein in Kidney Cancer].

A Study of the Relationship Between Expression Level of TRF1 Protein and Telomerase Activity in Human Acute Leukemia

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

Quantitative detection of telomere binding factor 2 gene expression in non-Hodgkin lymphoma with a real-time reverse transcription-polymerase chain reaction assay]

Expression of Human Telomerase Reverse Transcriptases and Association with WT1 Levels in Leukemia Cells

Expression Of Telomeric Repeat Binding Factor 1 Protein In Nonsmall Cell Lung Cancer With Human Telomerase Reverse Transcriptase Positive

Study on the Expression and Mutation of Human Telomeric Repeat Binding Factor ( Htrf1 ) in 10 Malignant Hematopoietic Cell Lines

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia from Two Cohorts.

Abnormal Expression and Clinical Significance of Telomeric Repeat Binding Factor 1 and Tankyrase 1 in Non-small Cell Lung Cancer

Expression of Telomerase Reverse Transcriptase Mrna in Acute Leukemia and Its Significance Detected by Quantitative Real-time RT-PCR

Expression and Clinical Significance of ID1 Gene in Acute Myeloid Leukemia

[Localization of Human Telomere Repeat Binding Factor 1 in Telomerase-Positive And-Negative Cells and Its Expression During Cell Cycle].

Clinical significance of determination of human telomerase reverse transcriptase messenger RNA in the leukemic cells by real-time quantitative PCR

[Clinical Significance of TET2 Gene Expression in 157 Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics].

Analysis of the Nuclear Localization Signal of TRF1 in Non-Small Cell Lung Cancer

The Fluctuation of Telomere Repeat Binding Factor 1 During Cell Cycle and Its Localization in Telomerase-Positive and Negative Cells.

Study on the Mutation of Human Telomeric Repeat Binding Factor 1 Gene in Malignant Hematopoietic Cell Lines

Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia]

The Expression of Telomeric Proteins and Their Probable Regulation of Telomerase during the Differentiation of All- trans -Retinoic Acid-Responsive and -Resistant Acute Promyelocytic Leukemia Cells